Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate whether enzymatic modification of starch in a food product using amylomaltase induces a lower glycemic response in healthy subjects compared to its unmodified counterpart.


Clinical Trial Description

A single-blind, randomized, cross-over study design will be applied. During each of the two study visits, healthy participants will consume an oatmeal porridge. One porridge will be treated will amylomaltase to modify the molecular structure of starch while the other porridge will serve as a control (unmodified counterpart). Blood glucose measurements will be taken postprandially at regular time points. ;


Study Design


NCT number NCT05537649
Study type Interventional
Source KU Leuven
Contact
Status Completed
Phase N/A
Start date June 23, 2021
Completion date October 8, 2021